{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:15:05Z","timestamp":1783440905247,"version":"3.54.6"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,7]],"date-time":"2017-11-07T00:00:00Z","timestamp":1510012800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1038\/mp.2017.192","type":"journal-article","created":{"date-parts":[[2017,11,7]],"date-time":"2017-11-07T16:14:14Z","timestamp":1510071254000},"page":"70-80","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Face and predictive validity of the Clock\u039419 mouse as an animal model for bipolar disorder: a systematic review"],"prefix":"10.1038","volume":"23","author":[{"given":"M","family":"Kristensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A A","family":"Nierenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S D","family":"\u00d8stergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,7]]},"reference":[{"key":"BFmp2017192_CR1","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(15)00241-X","volume":"387","author":"I Grande","year":"2016","unstructured":"Grande I, Berk M, Birmaher B, Vieta E . Bipolar disorder. Lancet 2016; 387: 1561\u20131572.","journal-title":"Lancet"},{"key":"BFmp2017192_CR2","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0140-6736(13)60989-7","volume":"381","author":"ML Phillips","year":"2013","unstructured":"Phillips ML, Kupfer DJ . Bipolar disorder diagnosis: challenges and future directions. Lancet 2013; 381: 1663\u20131671.","journal-title":"Lancet"},{"key":"BFmp2017192_CR3","first-page":"3390","volume":"6","author":"BL Mason","year":"2016","unstructured":"Mason BL, Brown ES, Croarkin PE . Historical underpinnings of bipolar disorder diagnostic criteria. Behav Sci (Basel) 2016; 6: 3390.","journal-title":"Behav Sci (Basel)"},{"issue":"10","key":"BFmp2017192_CR4","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.jaac.2010.05.017","volume":"49","author":"Kathleen Ries Merikangas","year":"2010","unstructured":"Merikangas KR, He J, Burstein M, Swanson SA, Avenevoli S, Cui L et al. Lifetime prevalence of mental disorders in U.S. adolescents: results from the national comorbidity survey Replication\u2013Adolescent supplement (NCS-A). J Am Acad Child Adolesc Psychiatry 49: 980\u2013989.","journal-title":"Journal of the American Academy of Child & Adolescent Psychiatry"},{"key":"BFmp2017192_CR5","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/S0140-6736(13)60855-7","volume":"381","author":"N Craddock","year":"2013","unstructured":"Craddock N, Sklar P . Genetics of bipolar disorder. Lancet 2013; 381: 1654\u20131662.","journal-title":"Lancet"},{"key":"BFmp2017192_CR6","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/nn.2647","volume":"13","author":"EJ Nestler","year":"2010","unstructured":"Nestler EJ, Hyman SE . Animal models of neuropsychiatric disorders. Nat Neurosci 2010; 13: 1161\u20131169.","journal-title":"Nat Neurosci"},{"key":"BFmp2017192_CR7","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/sj.mp.4001457","volume":"9","author":"JF Cryan","year":"2004","unstructured":"Cryan JF, Mombereau C . In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry 2004; 9: 326\u2013357.","journal-title":"Mol Psychiatry"},{"key":"BFmp2017192_CR8","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.biopsych.2015.09.002","volume":"79","author":"VE Cosgrove","year":"2016","unstructured":"Cosgrove VE, Kelsoe JR, Suppes T . Toward a valid animal model of bipolar disorder: how the research domain criteria help bridge the clinical-basic science divide. Biol Psychiatry 2016; 79: 62\u201370.","journal-title":"Biol Psychiatry"},{"key":"BFmp2017192_CR9","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.4088\/JCP.13r08507","volume":"75","author":"R Gonzalez","year":"2014","unstructured":"Gonzalez R . The relationship between bipolar disorder and biological rhythms. J Clin Psychiatry 2014; 75: e323\u2013e331.","journal-title":"J Clin Psychiatry"},{"issue":"Suppl 4","key":"BFmp2017192_CR10","doi-asserted-by":"crossref","first-page":"S676","DOI":"10.1016\/j.euroneuro.2011.07.007","volume":"21","author":"B Etain","year":"2011","unstructured":"Etain B, Milhiet V, Bellivier F, Leboyer M . Genetics of circadian rhythms and mood spectrum disorders. Eur Neuropsychopharmacol 2011; 21 (Suppl 4): S676\u2013S682.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFmp2017192_CR11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/ajmg.b.20038","volume":"123B","author":"F Benedetti","year":"2003","unstructured":"Benedetti F, Serretti A, Colombo C, Barbini B, Lorenzi C, Campori E et al. Influence of CLOCK gene polymorphism on circadian mood fluctuation and illness recurrence in bipolar depression. Am J Med Genet B Neuropsychiatr Genet 2003; 123B: 23\u201326.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"BFmp2017192_CR12","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/ajmg.b.30475","volume":"144B","author":"F Benedetti","year":"2007","unstructured":"Benedetti F, Dallaspezia S, Fulgosi MC, Lorenzi C, Serretti A, Barbini B et al. Actimetric evidence that CLOCK 3111\u2009T\/C SNP influences sleep and activity patterns in patients affected by bipolar depression. Am J Med Genet B Neuropsychiatr Genet 2007; 144B: 631\u2013635.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"BFmp2017192_CR13","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1080\/07420528.2016.1260026","volume":"34","author":"I Bollettini","year":"2017","unstructured":"Bollettini I, Melloni EM, Aggio V, Poletti S, Lorenzi C, Pirovano A et al. Clock genes associate with white matter integrity in depressed bipolar patients. Chronobiol Int 2017; 34: 212\u2013224.","journal-title":"Chronobiol Int"},{"key":"BFmp2017192_CR14","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.1073\/pnas.0609625104","volume":"104","author":"K Roybal","year":"2007","unstructured":"Roybal K, Theobold D, Graham A, DiNieri JA, Russo SJ, Krishnan V et al. Mania-like behavior induced by disruption of CLOCK. Proc Natl Acad Sci USA 2007; 104: 6406\u20136411.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp2017192_CR15","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1126\/science.8171325","volume":"264","author":"MH Vitaterna","year":"1994","unstructured":"Vitaterna MH, King DP, Chang AM, Kornhauser JM, Lowrey PL, McDonald JD et al. Mutagenesis and mapping of a mouse gene, clock, essential for circadian behavior. Science 1994; 264: 719\u2013725.","journal-title":"Science"},{"key":"BFmp2017192_CR16","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/genetics\/146.3.1049","volume":"146","author":"DP King","year":"1997","unstructured":"King DP, Vitaterna MH, Chang AM, Dove WF, Pinto LH, Turek FW et al. The mouse clock mutation behaves as an antimorph and maps within the W19H deletion, distal of kit. Genetics 1997; 146: 1049\u20131060.","journal-title":"Genetics"},{"key":"BFmp2017192_CR17","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0092-8674(00)80245-7","volume":"89","author":"DP King","year":"1997","unstructured":"King DP, Zhao Y, Sangoram AM, Wilsbacher LD, Tanaka M, Antoch MP et al. Positional cloning of the mouse circadian clock gene. Cell 1997; 89: 641\u2013653.","journal-title":"Cell"},{"key":"BFmp2017192_CR18","doi-asserted-by":"crossref","first-page":"9377","DOI":"10.1073\/pnas.0503584102","volume":"102","author":"CA McClung","year":"2005","unstructured":"McClung CA, Sidiropoulou K, Vitaterna M, Takahashi JS, White FJ, Cooper DC et al. Regulation of dopaminergic transmission and cocaine reward by the clock gene. Proc Natl Acad Sci USA 2005; 102: 9377\u20139381.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp2017192_CR19","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.","journal-title":"PLoS Med"},{"key":"BFmp2017192_CR20","doi-asserted-by":"crossref","first-page":"8138","DOI":"10.1523\/JNEUROSCI.20-21-08138.2000","volume":"20","author":"E Naylor","year":"2000","unstructured":"Naylor E, Bergmann BM, Krauski K, Zee PC, Takahashi JS, Vitaterna MH et al. The circadian clock mutation alters sleep homeostasis in the mouse. J Neurosci 2000; 20: 8138\u20138143.","journal-title":"J Neurosci"},{"key":"BFmp2017192_CR21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bbr.2013.04.023","volume":"249","author":"J van Enkhuizen","year":"2013","unstructured":"van Enkhuizen J, Minassian A, Young JW . Further evidence for ClockDelta19 mice as a model for bipolar disorder mania using cross-species tests of exploration and sensorimotor gating. Behav Brain Res 2013; 249: 44\u201354.","journal-title":"Behav Brain Res"},{"key":"BFmp2017192_CR22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2147\/NSS.S85754","volume":"8","author":"AK Gold","year":"2016","unstructured":"Gold AK, Sylvia LG . The role of sleep in bipolar disorder. Nat Sci Sleep 2016; 8: 207\u2013214.","journal-title":"Nat Sci Sleep"},{"key":"BFmp2017192_CR23","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ebiom.2016.08.019","volume":"11","author":"J- Moon","year":"2016","unstructured":"Moon J-, Cho C-, Son GH, Geum D, Chung S, Kim H et al. Advanced circadian phase in mania and delayed circadian phase in mixed mania and depression returned to normal after treatment of bipolar disorder. EBioMedicine 2016; 11: 285\u2013295.","journal-title":"EBioMedicine"},{"key":"BFmp2017192_CR24","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.drugalcdep.2013.08.024","volume":"133","author":"RE Bernardi","year":"2013","unstructured":"Bernardi RE, Spanagel R . The ClockDelta19 mutation in mice fails to alter the primary and secondary reinforcing properties of nicotine. Drug Alcohol Depend 2013; 133: 733\u2013739.","journal-title":"Drug Alcohol Depend"},{"key":"BFmp2017192_CR25","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1037\/a0037020","volume":"128","author":"RE Bernardi","year":"2014","unstructured":"Bernardi RE, Spanagel R . Enhanced extinction of contextual fear conditioning in ClockDelta19 mutant mice. Behav Neurosci 2014; 128: 468\u2013473.","journal-title":"Behav Neurosci"},{"key":"BFmp2017192_CR26","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/cmdc.201100188","volume":"6","author":"AP Kozikowski","year":"2011","unstructured":"Kozikowski AP, Gunosewoyo H, Guo S, Gaisina IN, Walter RL, Ketcherside A et al. Identification of a glycogen synthase kinase-3beta inhibitor that attenuates hyperactivity in CLOCK mutant mice. ChemMedChem 2011; 6: 1593\u20131602.","journal-title":"ChemMedChem"},{"key":"BFmp2017192_CR27","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/FBP.0b013e32835651fd","volume":"23","author":"R Arey","year":"2012","unstructured":"Arey R, McClung CA . An inhibitor of casein kinase 1 epsilon\/delta partially normalizes the manic-like behaviors of the ClockDelta19 mouse. Behav Pharmacol 2012; 23: 392\u2013396.","journal-title":"Behav Pharmacol"},{"key":"BFmp2017192_CR28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1034\/j.1601-183X.2003.00002.x","volume":"2","author":"A Easton","year":"2003","unstructured":"Easton A, Arbuzova J, Turek FW . The circadian clock mutation increases exploratory activity and escape-seeking behavior. Genes Brain Behav 2003; 2: 11\u201319.","journal-title":"Genes Brain Behav"},{"key":"BFmp2017192_CR29","doi-asserted-by":"crossref","first-page":"16314","DOI":"10.1523\/JNEUROSCI.4289-10.2010","volume":"30","author":"K Dzirasa","year":"2010","unstructured":"Dzirasa K, Coque L, Sidor MM, Kumar S, Dancy EA, Takahashi JS et al. Lithium ameliorates nucleus accumbens phase-signaling dysfunction in a genetic mouse model of mania. J Neurosci 2010; 30: 16314\u201316323.","journal-title":"J Neurosci"},{"key":"BFmp2017192_CR30","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1038\/npp.2011.33","volume":"36","author":"L Coque","year":"2011","unstructured":"Coque L, Mukherjee S, Cao JL, Spencer S, Marvin M, Falcon E et al. Specific role of VTA dopamine neuronal firing rates and morphology in the reversal of anxiety-related, but not depression-related behavior in the ClockDelta19 mouse model of mania. Neuropsychopharmacology 2011; 36: 1478\u20131488.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp2017192_CR31","doi-asserted-by":"crossref","first-page":"6449","DOI":"10.1523\/JNEUROSCI.6144-10.2011","volume":"31","author":"K Dzirasa","year":"2011","unstructured":"Dzirasa K, McGarity DL, Bhattacharya A, Kumar S, Takahashi JS, Dunson D et al. Impaired limbic gamma oscillatory synchrony during anxiety-related behavior in a genetic mouse model of bipolar mania. J Neurosci 2011; 31: 6449\u20136456.","journal-title":"J Neurosci"},{"key":"BFmp2017192_CR32","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/mp.2014.167","volume":"20","author":"MM Sidor","year":"2015","unstructured":"Sidor MM, Spencer SM, Dzirasa K, Parekh PK, Tye KM, Warden MR et al. Daytime spikes in dopaminergic activity drive rapid mood-cycling in mice. Mol Psychiatry 2015; 20: 1406\u20131419.","journal-title":"Mol Psychiatry"},{"key":"BFmp2017192_CR33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.psychres.2010.04.032","volume":"178","author":"W Perry","year":"2010","unstructured":"Perry W, Minassian A, Henry B, Kincaid M, Young JW, Geyer MA . Quantifying over-activity in bipolar and schizophrenia patients in a human open field paradigm. Psychiatry Res 2010; 178: 84\u201391.","journal-title":"Psychiatry Res"},{"key":"BFmp2017192_CR34","doi-asserted-by":"crossref","first-page":"e24185","DOI":"10.1371\/journal.pone.0024185","volume":"6","author":"A Minassian","year":"2011","unstructured":"Minassian A, Henry BL, Young JW, Masten V, Geyer MA, Perry W . Repeated assessment of exploration and novelty seeking in the human behavioral pattern monitor in bipolar disorder patients and healthy individuals. PLoS ONE 2011; 6: e24185.","journal-title":"PLoS ONE"},{"key":"BFmp2017192_CR35","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jad.2005.12.040","volume":"92","author":"SW Kim","year":"2006","unstructured":"Kim SW, Grant JE, Eckert ED, Faris PL, Hartman BK . Pathological gambling and mood disorders: clinical associations and treatment implications. J Affect Disord 2006; 92: 109\u2013116.","journal-title":"J Affect Disord"},{"key":"BFmp2017192_CR36","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0006-3223(01)01184-2","volume":"50","author":"W Perry","year":"2001","unstructured":"Perry W, Minassian A, Feifel D, Braff DL . Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania. Biol Psychiatry 2001; 50: 418\u2013424.","journal-title":"Biol Psychiatry"},{"key":"BFmp2017192_CR37","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jad.2015.06.053","volume":"185","author":"DT Acheson","year":"2015","unstructured":"Acheson DT, Eyler LT, Resovsky J, Tsan E, Risbrough VB . Fear extinction memory performance in a sample of stable, euthymic patients with bipolar disorder. J Affect Disord 2015; 185: 230\u2013238.","journal-title":"J Affect Disord"},{"key":"BFmp2017192_CR38","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jad.2014.06.023","volume":"167","author":"M Di Nicola","year":"2014","unstructured":"Di Nicola M, De Risio L, Pettorruso M, Caselli G, De Crescenzo F, Swierkosz-Lenart K et al. Bipolar disorder and gambling disorder comorbidity: current evidence and implications for pharmacological treatment. J Affect Disord 2014; 167: 285\u2013298.","journal-title":"J Affect Disord"},{"key":"BFmp2017192_CR39","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jad.2013.02.018","volume":"150","author":"K Fletcher","year":"2013","unstructured":"Fletcher K, Parker G, Paterson A, Synnott H . High-risk behaviour in hypomanic states. J Affect Disord 2013; 150: 50\u201356.","journal-title":"J Affect Disord"},{"key":"BFmp2017192_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2016.01.035","volume":"195","author":"I Kopeykina","year":"2016","unstructured":"Kopeykina I, Kim HJ, Khatun T, Boland J, Haeri S, Cohen LJ et al. Hypersexuality and couple relationships in bipolar disorder: a review. J Affect Disord 2016; 195: 1\u201314.","journal-title":"J Affect Disord"},{"key":"BFmp2017192_CR41","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.psychres.2015.10.021","volume":"230","author":"E Marengo","year":"2015","unstructured":"Marengo E, Martino DJ, Igoa A, Fassi G, Scapola M, Urtueta Baamonde M et al. Sexual risk behaviors among women with bipolar disorder. Psychiatry Res 2015; 230: 835\u2013838.","journal-title":"Psychiatry Res"},{"key":"BFmp2017192_CR42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1192\/bjp.bp.108.060368","volume":"196","author":"JH MacCabe","year":"2010","unstructured":"MacCabe JH, Lambe MP, Cnattingius S, Sham PC, David AS, Reichenberg A et al. Excellent school performance at age 16 and risk of adult bipolar disorder: National Cohort Study. Br J Psychiatry 2010; 196: 109\u2013115.","journal-title":"Br J Psychiatry"},{"key":"BFmp2017192_CR43","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nn.4040","volume":"18","author":"RA Power","year":"2015","unstructured":"Power RA, Steinberg S, Bjornsdottir G, Rietveld CA, Abdellaoui A, Nivard MM et al. Polygenic risk scores for schizophrenia and bipolar disorder predict creativity. Nat Neurosci 2015; 18: 953\u2013955.","journal-title":"Nat Neurosci"},{"key":"BFmp2017192_CR44","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1017\/S0033291715002299","volume":"46","author":"A Vreeker","year":"2016","unstructured":"Vreeker A, Boks MP, Abramovic L, Verkooijen S, van Bergen AH, Hillegers MH et al. High educational performance is a distinctive feature of bipolar disorder: a study on cognition in bipolar disorder, schizophrenia patients, relatives and controls. Psychol Med 2016; 46: 807\u2013818.","journal-title":"Psychol Med"},{"key":"BFmp2017192_CR45","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1038\/npp.2013.138","volume":"38","author":"AR Ozburn","year":"2013","unstructured":"Ozburn AR, Falcon E, Mukherjee S, Gillman A, Arey R, Spencer S et al. The role of clock in ethanol-related behaviors. Neuropsychopharmacology 2013; 38: 2393\u20132400.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp2017192_CR46","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00213-012-2704-2","volume":"223","author":"AR Ozburn","year":"2012","unstructured":"Ozburn AR, Larson EB, Self DW, McClung CA . Cocaine self-administration behaviors in ClockDelta19 mice. Psychopharmacology (Berl) 2012; 223: 169\u2013177.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFmp2017192_CR47","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1034\/j.1399-5618.2001.30403.x","volume":"3","author":"F Cassidy","year":"2001","unstructured":"Cassidy F, Ahearn EP, Carroll BJ . Substance abuse in bipolar disorder. Bipolar Disord 2001; 3: 181\u2013188.","journal-title":"Bipolar Disord"},{"key":"BFmp2017192_CR48","doi-asserted-by":"crossref","first-page":"492","DOI":"10.4088\/JCP.v62n0614","volume":"62","author":"JL Elmslie","year":"2001","unstructured":"Elmslie JL, Mann JI, Silverstone JT, Williams SM, Romans SE . Determinants of overweight and obesity in patients with bipolar disorder. J Clin Psychiatry 2001; 62: 492\u2013493, 486,91; quiz.","journal-title":"J Clin Psychiatry"},{"key":"BFmp2017192_CR49","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1399-5618.2011.00943.x","volume":"13","author":"JL Heffner","year":"2011","unstructured":"Heffner JL, Strawn JR, DelBello MP, Strakowski SM, Anthenelli RM . The co-occurrence of cigarette smoking and bipolar disorder: phenomenology and treatment considerations. Bipolar Disord 2011; 13: 439\u2013453.","journal-title":"Bipolar Disord"},{"key":"BFmp2017192_CR50","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1126\/science.1108750","volume":"308","author":"FW Turek","year":"2005","unstructured":"Turek FW, Joshu C, Kohsaka A, Lin E, Ivanova G, McDearmon E et al. Obesity and metabolic syndrome in circadian clock mutant mice. Science 2005; 308: 1043.","journal-title":"Science"},{"key":"BFmp2017192_CR51","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1176\/appi.ajp.2012.12050620","volume":"170","author":"D Vancampfort","year":"2013","unstructured":"Vancampfort D, Vansteelandt K, Correll CU, Mitchell AJ, De Herdt A, Sienaert P et al. Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators. Am J Psychiatry 2013; 170: 265\u2013274.","journal-title":"Am J Psychiatry"},{"key":"BFmp2017192_CR52","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4088\/JCP.13r08634","volume":"75","author":"SL McElroy","year":"2014","unstructured":"McElroy SL, Keck PE Jr . Metabolic syndrome in bipolar disorder: a review with a focus on bipolar depression. J Clin Psychiatry 2014; 75: 46\u201361.","journal-title":"J Clin Psychiatry"},{"key":"BFmp2017192_CR53","first-page":"S92","volume":"36","author":"MM Sidor","year":"2011","unstructured":"Sidor MM, Spencer S, Tye K, Warden M, Dzirasa K, Deisseroth K et al. Optogenetic control of mesolimbic dopamine neural activity recapitulates the anxiety-related phenotype of the clock-\u03b419 mouse model of mania. Neuropsychopharmacology 2011; 36: S92.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp2017192_CR54","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1471-4159.2012.07857.x","volume":"123","author":"S Spencer","year":"2012","unstructured":"Spencer S, Torres-Altoro MI, Falcon E, Arey R, Marvin M, Goldberg M et al. A mutation in CLOCK leads to altered dopamine receptor function. J Neurochem 2012; 123: 124\u2013134.","journal-title":"J Neurochem"},{"key":"BFmp2017192_CR55","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1399-5618.2009.00760.x","volume":"11","author":"DA Cousins","year":"2009","unstructured":"Cousins DA, Butts K, Young AH . The role of dopamine in bipolar disorder. Bipolar Disord 2009; 11: 787\u2013806.","journal-title":"Bipolar Disord"},{"key":"BFmp2017192_CR56","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/0269881114523864","volume":"28","author":"A de Bartolomeis","year":"2014","unstructured":"de Bartolomeis A, Buonaguro EF, Iasevoli F, Tomasetti C . The emerging role of dopamine-glutamate interaction and of the postsynaptic density in bipolar disorder pathophysiology: implications for treatment. J Psychopharmacol 2014; 28: 505\u2013526.","journal-title":"J Psychopharmacol"},{"key":"BFmp2017192_CR57","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/YCO.0000000000000122","volume":"28","author":"AE Whitton","year":"2015","unstructured":"Whitton AE, Treadway MT, Pizzagalli DA . Reward processing dysfunction in major depression, bipolar disorder and schizophrenia. Curr Opin Psychiatry 2015; 28: 7\u201312.","journal-title":"Curr Opin Psychiatry"},{"key":"BFmp2017192_CR58","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2990.2010.01128.x","volume":"37","author":"L Zhan","year":"2011","unstructured":"Zhan L, Kerr JR, Lafuente MJ, Maclean A, Chibalina MV, Liu B et al. Altered expression and coregulation of dopamine signalling genes in schizophrenia and bipolar disorder. Neuropathol Appl Neurobiol 2011; 37: 206\u2013219.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"BFmp2017192_CR59","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/mp.2013.12","volume":"19","author":"RN Arey","year":"2014","unstructured":"Arey RN, Enwright JF 3rd, Spencer SM, Falcon E, Ozburn AR, Ghose S et al. An important role for cholecystokinin, a CLOCK target gene, in the development and treatment of manic-like behaviors. Mol Psychiatry 2014; 19: 342\u2013350.","journal-title":"Mol Psychiatry"},{"key":"BFmp2017192_CR60","doi-asserted-by":"crossref","first-page":"e7476","DOI":"10.1371\/journal.pone.0007476","volume":"4","author":"C Beaule","year":"2009","unstructured":"Beaule C, Swanstrom A, Leone MJ, Herzog ED . Circadian modulation of gene expression, but not glutamate uptake, in mouse and rat cortical astrocytes. PLoS ONE 2009; 4: e7476.","journal-title":"PLoS ONE"},{"key":"BFmp2017192_CR61","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.biopsych.2007.03.017","volume":"62","author":"K Hashimoto","year":"2007","unstructured":"Hashimoto K, Sawa A, Iyo M . Increased levels of glutamate in brains from patients with mood disorders. Biol Psychiatry 2007; 62: 1310\u20131316.","journal-title":"Biol Psychiatry"},{"key":"BFmp2017192_CR62","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.biopsych.2009.12.004","volume":"67","author":"SL Eastwood","year":"2010","unstructured":"Eastwood SL, Harrison PJ . Markers of glutamate synaptic transmission and plasticity are increased in the anterior cingulate cortex in bipolar disorder. Biol Psychiatry 2010; 67: 1010\u20131016.","journal-title":"Biol Psychiatry"},{"key":"BFmp2017192_CR63","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pscychresns.2015.05.010","volume":"233","author":"A Ehrlich","year":"2015","unstructured":"Ehrlich A, Schubert F, Pehrs C, Gallinat J . Alterations of cerebral glutamate in the euthymic state of patients with bipolar disorder. Psychiatry Res 2015; 233: 73\u201380.","journal-title":"Psychiatry Res"},{"key":"BFmp2017192_CR64","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","volume":"67","author":"N Diazgranados","year":"2010","unstructured":"Diazgranados N, Ibrahim L, Brutsche NE, Newberg A, Kronstein P, Khalife S et al. A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry 2010; 67: 793\u2013802.","journal-title":"Arch Gen Psychiatry"},{"key":"BFmp2017192_CR65","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.biopsych.2011.12.010","volume":"71","author":"CA Zarate Jr","year":"2012","unstructured":"Zarate CA Jr, Brutsche NE, Ibrahim L, Franco-Chaves J, Diazgranados N, Cravchik A et al. Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biol Psychiatry 2012; 71: 939\u2013946.","journal-title":"Biol Psychiatry"},{"key":"BFmp2017192_CR66","doi-asserted-by":"crossref","first-page":"25326","DOI":"10.1074\/jbc.272.40.25326","volume":"272","author":"M Hong","year":"1997","unstructured":"Hong M, Chen DC, Klein PS, Lee VM . Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3. J Biol Chem 1997; 272: 25326\u201325332.","journal-title":"J Biol Chem"},{"key":"BFmp2017192_CR67","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1046\/j.1471-4159.2000.0721327.x","volume":"72","author":"G Chen","year":"1999","unstructured":"Chen G, Huang LD, Jiang YM, Manji HK . The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3. J Neurochem 1999; 72: 1327\u20131330.","journal-title":"J Neurochem"},{"key":"BFmp2017192_CR68","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/15622970902823202","volume":"10","author":"H Grunze","year":"2009","unstructured":"Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ et al. The world federation of societies of biological psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. World J Biol Psychiatry 2009; 10: 85\u2013116.","journal-title":"World J Biol Psychiatry"},{"key":"BFmp2017192_CR69","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/15622970903555881","volume":"11","author":"H Grunze","year":"2010","unstructured":"Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ et al. The world federation of societies of biological psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry 2010; 11: 81\u2013109.","journal-title":"World J Biol Psychiatry"},{"key":"BFmp2017192_CR70","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/15622975.2013.770551","volume":"14","author":"H Grunze","year":"2013","unstructured":"Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ et al. The world federation of societies of biological psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry 2013; 14: 154\u2013219.","journal-title":"World J Biol Psychiatry"},{"key":"BFmp2017192_CR71","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/BF00565622","volume":"10","author":"P Bech","year":"1976","unstructured":"Bech P, Thomsen J, Rafaelsen OJ . Long-term lithium treatment: effect on simulated driving and other psychological tests. Eur J Clin Pharmacol 1976; 10: 331\u2013335.","journal-title":"Eur J Clin Pharmacol"},{"key":"BFmp2017192_CR72","unstructured":"Schou M., Amdisen A, Thornsen K. The effect of lithium on the normal mindIn Baudis P, Peterova E, Sedievec V eds. De Psychiatrica Pregrediente II 1968."},{"key":"BFmp2017192_CR73","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.biopsych.2010.04.031","volume":"68","author":"S Mukherjee","year":"2010","unstructured":"Mukherjee S, Coque L, Cao J-, Kumar J, Chakravarty S, Asaithamby A et al. Knockdown of clock in the ventral tegmental area through RNA interference results in a mixed state of mania and depression-like behavior. Biol Psychiatry 2010; 68: 503\u2013511.","journal-title":"Biol Psychiatry"},{"key":"BFmp2017192_CR74","first-page":"150S","volume":"73","author":"N Edgar","year":"2013","unstructured":"Edgar N, Hoffman D, McClung C . Clock mutant mice are susceptible to developing a depression-like state following unpredictable chronic mild stress. Biol Psychiatry 2013; 73: 150S.","journal-title":"Biol Psychiatry"},{"key":"BFmp2017192_CR75","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.cpr.2005.06.004","volume":"25","author":"SL Johnson","year":"2005","unstructured":"Johnson SL . Life events in bipolar disorder: towards more specific models. Clin Psychol Rev 2005; 25: 1008\u20131027.","journal-title":"Clin Psychol Rev"},{"key":"BFmp2017192_CR76","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jaac.2013.07.009","volume":"52","author":"BI Goldstein","year":"2013","unstructured":"Goldstein BI, Strober M, Axelson D, Goldstein TR, Gill MK, Hower H et al. Predictors of first-onset substance use disorders during the prospective course of bipolar spectrum disorders in adolescents. J Am Acad Child Adolesc Psychiatry 2013; 52: 1026\u20131037.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"BFmp2017192_CR77","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s40263-017-0449-5","volume":"31","author":"A Naglich","year":"2017","unstructured":"Naglich A, Adinoff B, Brown ES . Pharmacological treatment of bipolar disorder with comorbid alcohol use disorder. CNS Drugs 2017; 31: 665\u2013674.","journal-title":"CNS Drugs"},{"key":"BFmp2017192_CR78","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.psychres.2011.04.030","volume":"188","author":"JJ Prisciandaro","year":"2011","unstructured":"Prisciandaro JJ, Brown DG, Brady KT, Tolliver BK . Comorbid anxiety disorders and baseline medication regimens predict clinical outcomes in individuals with co-occurring bipolar disorder and alcohol dependence: Results of a randomized controlled trial. Psychiatry Res 2011; 188: 361\u2013365.","journal-title":"Psychiatry Res"},{"key":"BFmp2017192_CR79","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1176\/ajp.2006.163.7.1199","volume":"163","author":"CL Bowden","year":"2006","unstructured":"Bowden CL, Calabrese JR, Ketter TA, Sachs GS, White RL, Thompson TR . Impact of lamotrigine and lithium on weight in obese and nonobese patients with bipolar I disorder. Am J Psychiatry 2006; 163: 1199\u20131201.","journal-title":"Am J Psychiatry"},{"key":"BFmp2017192_CR80","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40345-016-0068-y","volume":"4","author":"M Gitlin","year":"2016","unstructured":"Gitlin M . Lithium side effects and toxicity: prevalence and management strategies. Int J Bipolar Disord 2016; 4: 27.","journal-title":"Int J Bipolar Disord"},{"key":"BFmp2017192_CR81","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1399-5618.2006.00308.x","volume":"8","author":"G Sachs","year":"2006","unstructured":"Sachs G, Bowden C, Calabrese JR, Ketter T, Thompson T, White R et al. Effects of lamotrigine and lithium on body weight during maintenance treatment of bipolar I disorder. Bipolar Disord 2006; 8: 175\u2013181.","journal-title":"Bipolar Disord"},{"key":"BFmp2017192_CR82","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1590\/S1516-44462007000400007","volume":"29","author":"PJ Teixeira","year":"2007","unstructured":"Teixeira PJ, Rocha FL . The prevalence of metabolic syndrome among psychiatric inpatients in brazil. Rev Bras Psiquiatr 2007; 29: 330\u2013336.","journal-title":"Rev Bras Psiquiatr"},{"key":"BFmp2017192_CR83","first-page":"S603","volume":"39","author":"R Logan","year":"2014","unstructured":"Logan R, Ozburn A, Arey R, Zhang H, Zhu X, McClung C . Class I histone deacetylase (HDAC) inhibition reduces the mania-like behavioral phenotype of clock\u03b419 mutant mice. Neuropsychopharmacology 2014; 39: S603.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp2017192_CR84","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2174\/1570159X14666161017233642","volume":"15","author":"G Perugi","year":"2017","unstructured":"Perugi G, Medda P, Toni C, Mariani MG, Socci C, Mauri M . The role of electroconvulsive therapy (ECT) in bipolar disorder: fffectiveness in 522 patients with bipolar depression, mixed-state, mania and catatonic features. Curr Neuropharmacol 2017; 15: 359\u2013371.","journal-title":"Curr Neuropharmacol"},{"key":"BFmp2017192_CR85","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/bdi.12390","volume":"18","author":"TE Henriksen","year":"2016","unstructured":"Henriksen TE, Skrede S, Fasmer OB, Schoeyen H, Leskauskaite I, Bj\u00f8rke-Bertheussen J et al. Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial. Bipolar Disord 2016; 18: 221\u2013232.","journal-title":"Bipolar Disord"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/mp2017192.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/mp2017192","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/mp.2017.192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/mp2017192.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:17:39Z","timestamp":1684433859000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/mp2017192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,7]]},"references-count":85,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["BFmp2017192"],"URL":"https:\/\/doi.org\/10.1038\/mp.2017.192","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,7]]},"assertion":[{"value":"17 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ms Kristensen and Dr \u00d8stergaard reports no conflicts of interest. Dr Nierenberg reports the following conflicts of interest: Consultancy: Abbott Laboratories, Alkermes, American Psychiatric Association, Appliance Computing (Mindsite), Basliea, Brain Cells, Brandeis University, Bristol Myers Squibb, Clintara, Corcept, Dey Pharmaceuticals, Dainippon Sumitomo (now Sunovion), Eli Lilly and Company, EpiQ, L.P.\/Mylan, Forest, Genaissance, Genentech, GlaxoSmithKline, Healthcare Global Village, Hoffman LaRoche, Infomedic, Intra-Cellular Therapies, Lundbeck, Janssen Pharmaceutica, Jazz Pharmaceuticals, Medavante, Merck, Methylation Sciences, NeuroRx, Naurex, Novartis, PamLabs, Parexel, Pfizer, PGx Health, Otsuka, Ridge Diagnostics Shire, Schering-Plough, Somerset, Sunovion, Takeda Pharmaceuticals, Targacept and Teva; consulted through the MGH Clinical Trials Network and Institute (CTNI) for Astra Zeneca, Brain Cells, Dianippon Sumitomo\/Sepracor, Johnson and Johnson, Labopharm, Merck, Methylation Science, Novartis, PGx Health, Shire, Schering-Plough, Targacept and Takeda\/Lundbeck Pharmaceuticals, NeuroRx Pharma, Pfizer and Physician\u2019s Postgraduate Press. Grants\/Research support: American Foundation for Suicide Prevention, AHRQ, Brain and Behavior Research Foundation, Bristol-Myers Squibb, Cederroth, Cephalon, Cyberonics, Elan, Eli Lilly & Company, Forest, GlaxoSmithKline, Intra-Cellular Therapies, Janssen Pharmaceuticals, Lichtwer Pharma, Marriott Foundation, Mylan, NIMH, PamLabs, Patient Centered Outcomes Research Institute (PCORI), Pfizer Pharmaceuticals, Shire, Stanley Foundation, Takeda\/Lundbeck and Wyeth-Ayerst. Honoraria: Belvoir Publishing, University of Texas Southwestern Dallas, Brandeis University, Bristol-Myers Squibb, Hillside Hospital, American Drug Utilization Review, American Society for Clinical Psychopharmacology, Baystate Medical Center, Columbia University, CRICO, Dartmouth Medical School, Health New England, Harold Grinspoon Charitable Foundation, IMEDEX, International Society for Bipolar Disorder, Israel Society for Biological Psychiatry, Johns Hopkins University, MJ Consulting, New York State, Medscape, MBL Publishing, MGH Psychiatry Academy, National Association of Continuing Education, Physicians Postgraduate Press, SUNY Buffalo, University of Wisconsin, University of Pisa, University of Michigan, University of Miami, University of Wisconsin at Madison, APSARD, ISBD, SciMed, Slack Publishing and Wolters Klower Publishing, ASCP, NCDEU, Rush Medical College, Yale University School of Medicine, NNDC, Nova Southeastern University, NAMI, Institute of Medicine, CME Institute, ISCTM, World Congress on Brain Behavior and Emotion, Congress of the Hellenic Society for Basic and Clinical Pharmacology and ADAA. Stock: Appliance Computing (MindSite), Brain Cells, Medavante. Copyrights: Clinical Positive Affect Scale and the MGH Structured Clinical Interview for the Montgomery Asberg Depression Scale exclusively licensed to the MGH Clinical Trials Network and Institute (CTNI). Speaker Bureaus: none since 2003.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}